VIR stock

Vir Biotechnology Inc (VIR) financials · rev $68.6M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Vir Biotechnology Inc (VIR) rev $68.6M.

Cached annual income statement
LineFY2025FY2024
Revenue$68.6M$74.2M
Cost of Revenue$26.0K$845.0K
Gross Profit$68.5M$73.4M
Operating Income-$479.3M-$587.2M
Net Income-$438.0M-$522.0M
EPS (Diluted)-$3.16-$3.83
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.00B$1.40B
Current Assets$514.1M$1.04B
Cash & Equivalents$232.2M$222.9M
PP&E$55.6M$63.2M
Total Liabilities$237.5M$248.4M
Current Liabilities$92.8M$119.7M
Shareholders' Equity$765.3M$1.15B
Retained Earnings-$1.20B-$759.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$391.8M-$446.4M
CapEx$4.83M$7.30M
Investing Cash Flow$310.4M$499.4M
Financing Cash Flow$3.79M$4.39M
Net Change in Cash-$77.6M$57.4M
Free Cash Flow-$396.6M-$453.7M
These statements as JSON? API free 100/day

FAQ

What is VIR P/E and revenue?

Vir Biotechnology Inc (VIR) rev $68.6M.

What is VIR revenue?

Vir Biotechnology Inc last cached revenue is $68.6M (FY2025).

Is VIR profitable?

Vir Biotechnology Inc last cached net income is -$438.0M (FY2025).

What are VIR total assets?

Vir Biotechnology Inc last cached total assets are $1.00B (FY2025).

What is VIR free cash flow?

Vir Biotechnology Inc last cached free cash flow is -$396.6M (FY2025).

Not investment advice. Cached statements, not a live tape.